DOI QR코드

DOI QR Code

A Novel Approach for Sericin-Conjugated Silver Nanoparticle Synthesis and Their Potential as Microbicide Candidates

  • Lv, Xiaowen (Department of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine) ;
  • Wang, Huanru (Center for Public Health Research, Medical School, Nanjing University) ;
  • Su, Airong (Central Laboratory, The Second Affiliated Hospital of Nanjing Medical University) ;
  • Chu, Ying (Central Laboratory, The Affiliated Wujin People's Hospital of Jiangsu University)
  • Received : 2018.03.08
  • Accepted : 2018.05.11
  • Published : 2018.08.28

Abstract

Silver nanoparticles have been widely applied for biomedical areas owing to their potent antiviral and antibacterial activities. Synthesis of silver nanoparticles using biomacromolecules is more efficient, environment-friendly, and cost-saving compared with the traditional approach. In this paper, a novel approach was developed to establish a reaction system with $Ag^+-BH4^--sericin$ to synthesize silver nanoparticles conjugated to sericin (AgNPs-Sericin). Sericin could be as a good dispersant and stabilizing agent, which is able to modify nanoscaled AgNPs, the average diameter of which was only $3.78{\pm}1.14nm$ prepared in a 0.3 mg/ml sericin solution. The characterizations of the AgNPs-Sericin were determined by FTIR, thermogravimetry, and XRD analyses. The results showed that the synthesized AgNPs conjugated with sericin as organic phase. Via SAED and XRD analysis, we showed that these AgNPs formed polycrystalline powder with a face-centered cubic structure of bulk metals. Moreover, we investigated the antiviral and antibacterial activities of AgNPs-Sericin, and the results showed that AgNPs-Sericin exhibited potent anti-HIV-1 activity against CCR5-tropic and CXCR4-tropic strains, but no significant cytotoxicity was found toward human genital epithelial cells compared with free silver ions, which are accepted as a commonly used potent antimicrobial agent. Moreover, its antibacterial activity was determined via flow cytometry. The results showed that AgNPs-Sericin could suppress gram-negative (E. coli) and gram-positive (S. aureus) bacteria, but more was potent for the gram-negative one. We concluded that our AgNPs-Sericin could be a potential candidate as a microbicide or antimicrobial agent to prevent sexually transmitted infections.

Keywords

References

  1. Alanis AJ. 2005. Resistance to antibiotics: are we in the postantibiotic era? Arch. Med. Res. 36: 697-705. https://doi.org/10.1016/j.arcmed.2005.06.009
  2. Fauci AS. 1999. The AIDS epidemic - considerations for the 21st century. N. Engl. J. Med. 341: 1046-1050. https://doi.org/10.1056/NEJM199909303411406
  3. Kahn JO, Walker BD. 1998. Acute human immunodeficiency virus type 1 infection. N. Engl. J. Med. 339: 33-39. https://doi.org/10.1056/NEJM199807023390107
  4. Stone A. 2002. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat. Rev. Drug Discov. 1: 977-985. https://doi.org/10.1038/nrd959
  5. Balzarini J, Van Damme L. 2007. Microbicide drug candidates to prevent HIV infection. Lancet 369: 787-797. https://doi.org/10.1016/S0140-6736(07)60202-5
  6. Neu HC. 1992. The crisis in antibiotic resistance. Science 257: 1064-1073. https://doi.org/10.1126/science.257.5073.1064
  7. Bonnemann H, Richards RM. 2001. Nanoscopic metal particles − synthetic methods and potential applications. Eur. J. Inorg. Chem. 2001: 2455-2480. https://doi.org/10.1002/1099-0682(200109)2001:10<2455::AID-EJIC2455>3.0.CO;2-Z
  8. Hirsch LR, Stafford R, Bankson J, Sershen S, Rivera B, Price R, et al. 2003. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100: 13549-13554. https://doi.org/10.1073/pnas.2232479100
  9. Liau S, Read D, Pugh W, Furr J, Russell A. 1997. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett. Appl. Microbiol. 25: 279-283. https://doi.org/10.1046/j.1472-765X.1997.00219.x
  10. Nomiya K, Yoshizawa A, Tsukagoshi K, Kasuga NC, Hirakawa S, Watanabe J. 2004. Synthesis and structural characterization of silver(I), aluminium(III) and cobalt(II) complexes with 4-isopropyltropolone (hinokitiol) showing noteworthy biological activities. Action of silver(I)-oxygen bonding complexes on the antimicrobial activities. J. Inorg. Biochem. 98: 46-60. https://doi.org/10.1016/j.jinorgbio.2003.07.002
  11. Gupta A, Silver S. 1998. Molecular genetics: silver as a biocide: will resistance become a problem? Nat. Biotechnol. 16: 888. https://doi.org/10.1038/nbt1098-888
  12. Fedlheim DL, Foss CA. 2001. Metal Nanoparticles: Synthesis, Characterization, and Applications. CRC Press, Boca Raton, FL.
  13. Lok C-N, Ho C-M, Chen R, He Q-Y, Yu W-Y, Sun H, et al. 2006. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res. 5: 916-924. https://doi.org/10.1021/pr0504079
  14. Das R, Gang S, Nath SS. 2011. Preparation and antibacterial activity of silver nanoparticles. J. Biomater. Nanobiotechnol. 2: 472-475. https://doi.org/10.4236/jbnb.2011.24057
  15. Li C, Wang X, Chen F, Zhang C, Zhi X, Wang K, et al. 2013. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials 34: 3882-3890. https://doi.org/10.1016/j.biomaterials.2013.02.001
  16. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. 2005. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 3: 1-10. https://doi.org/10.1186/1477-3155-3-1
  17. Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R. 2009. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug. Chem. 20: 1497-1502. https://doi.org/10.1021/bc900215b
  18. AshaRani P, Low Kah Mun G, Hande MP, Valiyaveettil S. 2008. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3: 279-290.
  19. Zhang YQ. 2002. Applications of natural silk protein sericin in biomaterials. Biotechnol. Adv. 20: 91-100. https://doi.org/10.1016/S0734-9750(02)00003-4
  20. Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79: 10108-10125. https://doi.org/10.1128/JVI.79.16.10108-10125.2005
  21. Johnson V, Byington R, Aldovani A, Walker B. 1990. Infectivity assay (virus yield assay), pp. 71-76. In Aldovani A and Walker BD (eds.), Techniques in HIV research. Stockton Press, New York, NY.
  22. Pan H, Zhang Y, He G-X, Katagori N, Chen H. 2014. A comparison of conventional methods for the quantification of bacterial cells after exposure to metal oxide nanoparticles. BMC Microbiol. 14: 222. https://doi.org/10.1186/s12866-014-0222-6
  23. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. 2005. The bactericidal effect of silver nanoparticles. Nanotechnology 16: 2346-2353. https://doi.org/10.1088/0957-4484/16/10/059
  24. Ravichandran R. 2009. Nanotechnology-based drug delivery systems. Nanobiotechnology 5: 17-33. https://doi.org/10.1007/s12030-009-9028-2
  25. Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. 2011. Silver nanoparticles as potential antiviral agents. Molecules 16: 8894-8918. https://doi.org/10.3390/molecules16108894

Cited by

  1. Limitations of Recent Studies Dealing with the Antibacterial Properties of Silver Nanoparticles: Fact and Opinion vol.9, pp.12, 2018, https://doi.org/10.3390/nano9121775
  2. Synthesis of sericin-conjugated silver nanoparticles and their potential antimicrobial activity vol.60, pp.5, 2020, https://doi.org/10.1002/jobm.201900567
  3. Sericin: A Versatile Protein Biopolymer with Therapeutic Significance vol.26, pp.None, 2018, https://doi.org/10.2174/1381612826666200612165253
  4. Sericin based nanoformulations: a comprehensive review on molecular mechanisms of interaction with organisms to biological applications vol.19, pp.1, 2021, https://doi.org/10.1186/s12951-021-00774-y